Lead
New national data released Jan. 22, 2026, show a decline in deaths from cardiovascular disease and stroke in the United States, with roughly 25,000 fewer deaths in 2023 than in 2022. Heart disease remains the country’s leading cause of death, occurring about once every 34 seconds. Researchers and clinicians attribute part of the improvement to recovery after pandemic disruptions and emphasize prevention — especially identifying and treating high blood pressure. Public-health experts say combining individual behavior changes with community and policy-level interventions will be essential to sustain the trend.
Key Takeaways
- 2023 saw about 25,000 fewer deaths from cardiovascular disease and stroke than 2022, according to the American Heart Association (AHA) annual report released Jan. 22, 2026.
- Heart disease still kills roughly one person every 34 seconds in the U.S., and it remains the leading cause of death for men and women.
- Nearly half of U.S. adults carry a hypertension diagnosis; controlling blood pressure is the most modifiable cardiovascular risk after quitting tobacco.
- Obesity and diabetes continue as major drivers of heart disease, with prevention and treatment delivered through medicines and lifestyle changes.
- Community design — such as adding safe green spaces — and food-supply policies (e.g., sodium reduction) are cited as effective population-level measures.
- The AHA promotes “Life’s Essential 8”: diet, physical activity, sleep, tobacco avoidance, and managing blood sugar, blood pressure, cholesterol and weight.
Background
Cardiovascular disease has long been the leading cause of death in the United States, affecting both sexes and all major demographic groups. During the COVID-19 pandemic, heart-related mortality rose, interrupting a prior decade of steady declines in some subgroups. The AHA’s annual report tracks these shifts and highlights underlying risk factors—chief among them hypertension, diabetes and obesity—that shape population-level trends.
High blood pressure is frequently asymptomatic, which helps explain why many people are unaware they have it. Clinical and public-health leaders emphasize routine screening and affordable treatment options, noting that effective medications and lifestyle changes can markedly lower risk. At the same time, upstream determinants such as neighborhood design, access to healthy foods and socioeconomic barriers influence how easily individuals can adopt heart-healthy behaviors.
Main Event
The American Heart Association published its latest annual statistics on Jan. 22, 2026, reporting approximately 25,000 fewer deaths from cardiovascular disease and stroke in 2023 compared with the prior year. Authors of the report and affiliated clinicians framed the fall as partly a rebound from pandemic-period disruptions, but also as a signal that stronger prevention efforts can translate into measurable gains.
Clinicians quoted in the report urged a two-pronged approach: system-level changes (policy, community infrastructure, health-care access) coupled with individual care, particularly detection and treatment of hypertension. Dr. Stacey Rosen, leader at the Katz Institute for Women’s Health and AHA president, described the past five pandemic-affected years as an anomaly while calling for continued focus on modifiable risks.
Researchers also highlighted treatment advances and the availability of low-cost medications for blood-pressure control. Dr. Sadiya Khan of Northwestern University — a contributor to the report — emphasized that lowering blood pressure with accessible therapies can add years to life and reduce stroke, heart disease and dementia risk. Public-health proposals in the AHA policy paper extend from reducing sodium in processed foods to scaling diabetes-prevention programs.
Analysis & Implications
The reported reduction in deaths is encouraging, but analysts caution that a single-year improvement does not guarantee a long-term reversal of decades-long burdens. Much depends on whether declines are broad-based across ages, races and regions or concentrated in certain subgroups; the AHA report notes variation but calls for targeted action where gains lag. Sustained progress will require integrating clinical care, community investment and policy levers that shift population risk.
Hypertension control stands out as a high-impact target because it is common and treatable. Public-health modeling indicates that modest improvements in average blood pressure at the population level can prevent large numbers of heart attacks and strokes. Similarly, reducing obesity and improving diabetes management through a mix of clinical programs, food-policy changes and built-environment improvements will multiply benefits.
From a policy perspective, interventions that change the default environment—such as lowering sodium in processed foods or expanding safe, green spaces for activity—tend to be more equitable and sustainable than interventions that rely purely on individual willpower. Financial incentives for risk-factor control and broader insurance coverage for preventive services could accelerate adoption of proven measures. International observers will watch U.S. policy responses closely because American patterns shape global research and product markets.
Comparison & Data
| Metric | 2022 | 2023 | Change |
|---|---|---|---|
| Cardiovascular & stroke deaths (aggregate) | — | — | −25,000 deaths (2022→2023) |
| U.S. average frequency | One death every 34 seconds | — | |
The AHA report emphasizes the net reduction of about 25,000 deaths but presents variation by age, sex and region that require closer study. Analysts say the headline decline should prompt deeper examination of which interventions worked in specific communities and which populations continue to face elevated risk.
Reactions & Quotes
Health leaders welcomed the overall decline while urging continued preventive focus. Their responses underline both optimism and caution about sustaining improvement.
“The last five years, as health overall was impacted by the COVID pandemic, was something of an anomaly,”
Dr. Stacey Rosen, American Heart Association president
Rosen used the characterization to argue that data are returning to pre-pandemic patterns and that prevention must remain central to policy and clinical practice.
“Improving high blood pressure with medicine has never been easier,”
Dr. Sadiya Khan, Northwestern University
Khan highlighted the availability of inexpensive therapies and said better blood-pressure control can prevent heart disease, stroke and dementia, reinforcing the call for widespread screening and treatment.
“There are many options and ways to move forward,”
Dr. Anand Parekh, University of Michigan (AHA policy author)
Parekh framed the policy paper that accompanies the AHA report, listing measures from sodium reduction to expanded obesity and diabetes programs as viable paths for policymakers.
Unconfirmed
- Whether the 25,000 fewer deaths represent a sustained downward trend across all demographic groups remains to be confirmed by multi-year analyses.
- The relative contribution of specific policies (for example, sodium reduction or new clinical programs) to the decline has not been definitively established.
- Regional and socioeconomic variations in the reported decline need fuller peer-reviewed analysis to confirm where gains were largest and where gaps persist.
Bottom Line
The AHA’s 2026 report signals a measurable improvement in U.S. cardiovascular and stroke mortality in 2023, with an estimated 25,000 fewer deaths than in 2022. That progress likely reflects a combination of post-pandemic normalization and targeted prevention efforts, but it is not yet proof of a durable reversal of long-term trends.
To lock in gains, experts recommend prioritizing widespread blood-pressure screening and treatment, expanded access to obesity and diabetes prevention programs, and community-level changes that promote healthy behaviors—like more green spaces and lower-sodium food supplies. For individuals, adopting incremental, specific habits that align with Life’s Essential 8 offers a realistic path to reduce personal risk over time.